UBS 18/02/2010 1 Buy $41.10 20.9%
A good operational result, obscured by swine flu and plasma margin growth with profits up 23%, UBS says.
In terms of outlook, UBS feels its all about plasma and the 4-year roll out of Privigen margin improvements.
While the 1H result was, solid, the broker feels share price gains will be step by step.
- Forums
- ASX - By Stock
- credit suisse - $40.50
UBS 18/02/2010 1 Buy $41.10 20.9%A good operational result,...
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$303.99 |
Change
-2.040(0.67%) |
Mkt cap ! $146.0B |
Open | High | Low | Value | Volume |
$302.89 | $303.99 | $299.73 | $160.3M | 529.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 434 | $303.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$304.00 | 1426 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 9894 | 333.680 |
1 | 172 | 327.080 |
1 | 141 | 326.100 |
1 | 703 | 324.580 |
14 | 5970 | 318.520 |
Price($) | Vol. | No. |
---|---|---|
273.010 | 155 | 1 |
273.020 | 5926 | 3 |
278.090 | 130 | 1 |
278.210 | 45 | 1 |
280.600 | 452 | 2 |
Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |